Citrato liasi ATP

ATP Citrate Lyase inhibitors are compounds that target the enzyme ATP citrate lyase, which plays a key role in the biosynthesis of fatty acids and cholesterol by converting citrate to acetyl-CoA. In the context of neuroscience, these inhibitors are of interest due to their potential effects on lipid metabolism in the brain, which is crucial for maintaining neuronal function and integrity. Inhibiting ATP citrate lyase can have implications for neurodegenerative diseases, where lipid metabolism is often dysregulated. At CymitQuimica, we offer ATP citrate lyase inhibitors to support your research in brain metabolism, neurodegeneration, and therapeutic development.